The company announced in late 2021 plans to split its personal care brands into a separate company to create more targeted growth strategies. A press release said the new company, which will include Aveeno, Band-Aid, Listerine, Neutrogena, Tylenol, Johnson’s and Dr.Ci:Labo, will separate from J&J in 2023.
According to the press release, the name comes from the work “ken,” meaning knowledge, and “vue” referencing the word view. The concept behind the company will be “Realize the Extraordinary Power of Everyday Care.”
“Today’s announcement is another milestone for the Consumer Health business,” Joaquin Duato, CEO of J&J said in the release. “Kenvue is poised to thrive as a standalone company with a leading portfolio of brands consumers love and trust. I’m confident in this team and excited to see what the future holds.”
Once the company separation has been completed, Kenvue will be selling in more than 100 countries. The press release said more information on the company will be released at a later date.
Click through to read more about the split and J&J’s place in the market.